middle.news
How Resonance Health Is Driving Growth with Record SaMD Contracts and Clinical Trials
12:41pm on Wednesday 29th of October, 2025 AEDT
•
Healthcare Technology
Read Story
How Resonance Health Is Driving Growth with Record SaMD Contracts and Clinical Trials
12:41pm on Wednesday 29th of October, 2025 AEDT
Key Points
Positive quarterly cash flow with $3.1M receipts and $0.1M net operating cash flow
29 patients dosed in $13.8M major pharma clinical trial, on track for milestones
Expansion to three TrialsWest clinical trial sites supporting revenue growth
Record $5.2M in multi-year SaMD contracts, with total orders potentially exceeding $8.5M
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE